Market Cap:
$2.4T
3.01%
24h Vol:
$120.6B
117.66%
Dominance:
BTC 56.40%
-0.39%
ETH 9.32%
3.73%

Live GenomesDAO GENOME (GENOME) vs ZetaChain Bridged USDC.ETH (ZetaChain) (USDC.ETH) Comparison

What would the price and market cap of GenomesDAO GENOME (GENOME) be if the market cap of GenomesDAO GENOME (GENOME) was equal to the market cap of ZetaChain Bridged USDC.ETH (ZetaChain) (USDC.ETH)?

Compare
$
Price of GenomesDAO GENOME if it had ZetaChain Bridged USDC.ETH (ZetaChain)'s market cap.
$00.70x

Difference between GenomesDAO GENOME (GENOME) and ZetaChain Bridged USDC.ETH (ZetaChain) (USDC.ETH)

GENOME Difference USDC.ETH
Market Cap$361,8101.43x$252,788
Price$ 0.000361922774.09x$1
Volume (24h)$1,820.491.24x$1,472.51
FDV$361,8101.43x$252,788
Circulating Supply1,000,000,0003972.19x251,750.09
Total Supply1,000,000,0003972.19x251,750.09
% in Circulation100.00%1.00x100.00%
Max Supply1,000,000,000-∞
We're committed to your privacy. CryptoCalc uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

GenomesDAO GENOME or ZetaChain Bridged USDC.ETH (ZetaChain) FAQ

Is GenomesDAO GENOME better than ZetaChain Bridged USDC.ETH (ZetaChain)?

Choosing between GenomesDAO GENOME and ZetaChain Bridged USDC.ETH (ZetaChain) depends on their tokenomics metrics, current market trends, your personal goals and how you plan to use cryptocurrency.

At the moment, GenomesDAO GENOME is priced at $ 0.00036192 with a market cap of $361,810, while ZetaChain Bridged USDC.ETH (ZetaChain) trades around $1 with a market cap of $252,788. In most cases, cryptocurrencies with a lower market cap have higher upside and ROI potential.

To choose an asset that better suits your needs, it’s crucial to consider not only financial metrics but also the technology under cryptocurrency, utilities, community support, and developers' activity.Each has strengths in different areas, so it's best to consider what matters most to you when deciding.

Should I buy GenomesDAO GENOME or ZetaChain Bridged USDC.ETH (ZetaChain)?

When deciding whether to buy GenomesDAO GENOME or ZetaChain Bridged USDC.ETH (ZetaChain), it's important to compare their current market positions and long-term potential.

Right now, GenomesDAO GENOME has a market cap of $361,810 and a daily trading volume of $1,820.49, while ZetaChain Bridged USDC.ETH (ZetaChain)'s market cap is $252,788 with $1,472.51 traded daily. Usually, a coin with lower market cap and higher trading volume has higher potential.

Also, you should consider factors like your risk tolerance, time horizon, and the evolving crypto landscape before making a decision. Research both projects carefully to see which one aligns better with your investment plans.

Should I invest in GenomesDAO GENOME or ZetaChain Bridged USDC.ETH (ZetaChain)?

Choosing whether to invest in GenomesDAO GENOME or ZetaChain Bridged USDC.ETH (ZetaChain) involves understanding their market positions and technological potential. While the latter requires more extensive research, market position can be analyzed based on stats like price, market cap, and FDV.

For example, GenomesDAO GENOME has a market cap of $361,810 with a price of $ 0.00036192 and FDV of $361,810, while ZetaChain Bridged USDC.ETH (ZetaChain) has a market cap of $252,788, FDV of $252,788 and priced at $1. Coins with higher FDV and market cap are more “heavy” in terms of demonstrating wider positive price action. On the contrary, they are more liquid and less volatile, which is better for investing higher capital in them.

As with any investment, past performance does not guarantee future results, so it’s important to make decisions based on thorough research of fundamental factors as well.

What is the difference between GenomesDAO GENOME and ZetaChain Bridged USDC.ETH (ZetaChain)?

The difference between GenomesDAO GENOME and ZetaChain Bridged USDC.ETH (ZetaChain) lies primarily in their design and intended use.

At the same time, GenomesDAO GENOME holds a market cap of $361,810 with circulation supply of 1,000,000,000 and total supply of 1,000,000,000, while ZetaChain Bridged USDC.ETH (ZetaChain) has a market cap of $252,788 with circulation supply of 251,750.09 and total supply of 251,750.09.

Each project offers unique advantages depending on what you're looking for — whether it's transaction speed, network security, smart contracts, or decentralization. Understanding these distinctions can help you decide which project aligns more closely with your interests.

GenomesDAO GENOME vs ZetaChain Bridged USDC.ETH (ZetaChain) long term

Considering GenomesDAO GENOME vs ZetaChain Bridged USDC.ETH (ZetaChain) for the long term requires examining their roadmaps, market trends, and adoption rates. Other factors that influence the development of any cryptocurrency are tokenomics metrics, the team behind a project, the amount of investments raised, and financial projections.

GenomesDAO GENOME currently has a market cap of $361,810, ATH of $ 0.058627 at 2025-01-03 18:56, and holds market cap rank #3971 while ZetaChain Bridged USDC.ETH (ZetaChain) has a market cap of $252,788, ATH of $2.42 at 2025-10-11 17:29, and holds market cap rank #5589. The rule is the following: the lower the market cap, FDV and market cap rank, the greater growth upside a coin has. However, higher market cap, FDV and market cap rank mean that a coin is more liquid, popular and secure as a store of value.

Future success could depend on technology updates, regulatory acceptance, and real-world use case growth. Long-term performance will likely be influenced by ecosystem expansion, developer activity, and macroeconomic factors.

LogoFollow usX SocialTelegram Social
Subscribe to our Newsletter
We're committed to your privacy. CryptoCalc uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.
© 2026 CryptoCalc. All rights reserved.